Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

104.41
Delayed Data
As of May 18
 -1.71 / -1.61%
Today’s Change
29.46
Today|||52-Week Range
108.00
+77.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues7.5M75.9M38.1M44.0M
 
 
 
 
 
Depreciation And Amortization552.0K564.0K587.0K613.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.1M21.1M23.1M26.6M
 
 
 
 
 
Research And Development15.4M16.5M18.0M21.5M
 
 
 
 
 
Total Operating Expenses20.6M21.6M23.7M27.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.1M54.3M14.4M16.9M
 
 
 
 
 
Extraordinary Credit0.000.0041.0K0.00
 
 
Extraordinary Charge-17.0K-114.0K--0.00
 
 
 
Interest Expense On Debt11.0K9.0K9.0K0.00
 
 
 
 
Other Expenses0.000.000.00-11.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.5M55.0M15.3M17.9M
 
 
 
 
 
Income Taxes-4.1M-18.4M-3.6M-5.4M
 
 
 
 
 
Net Income-8.4M36.5M11.7M12.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.1M19.1M19.1M19.2M
 
 
 
 
 
Shares To Calculate EPS Diluted19.1M19.6M19.9M20.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.44$1.86$0.59$0.61
 
 
 
 
 
EPS Diluted-$0.44$1.86$0.59$0.61